TT-228

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTT-228
Drug Alias NameTT-228
ClassificationSmall molecules
Mechanisms of ActionAdenosine A2a receptor antagonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsColorectal NeoplasmsBreast NeoplasmsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTeon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsBreast NeoplasmsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A